Bergen, Norway 1 December 2022 

Lifecare AS will present Q3 2022 financial and operational status in a webcast
Tuesday 6 December. 
   
For more information of the webcast and other news, read Lifecare's latest
newsletter: https://lifecare.no/news/information-from-lifecare-november-2022/

This is Lifecare: 
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE). 

Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no,
+47 40 05 90 40 

This stock exchange announcement was published by Joacim Holter, CEO at Lifecare
AS, on 1.12.22 at 09:58 CET.